Volumetric Modulated Arc Therapy Decreases Incidence of Acute Rectal Toxicity in the Treatment of Low- and Intermediate-Risk Prostate Cancer

被引：1
|
作者：
Dominello, M. [1 ]
Ku, K. [1 ]
Chen, G. [1 ]
Tait, L. [1 ]
Snyder, M. [1 ,2 ]
McSpadden, E. [1 ]
Maier, J. [1 ,2 ]
Miller, S. [1 ]
Konski, A. [1 ]
机构：
[1] Wayne State Univ, Detroit, MI USA
[2] Karmanos Canc Ctr, Detroit, MI USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 84卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2012.07.964
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [21] GENITOURINARY TOXICITY IN MODERATE HYPOFRACTIONATION PROSTATE CANCER WITH VOLUMETRIC MODULATED ARC THERAPY
    Fersino, Sergio
    Mazzola, Rosario
    Ricchetti, Francesco
    Levra, Niccolo Giaj
    Fiorentino, Alba
    Naccarato, Stefania
    Sicignano, Gianluisa
    Ruggieri, Ruggero
    Cavalleri, Stefano
    Alongi, Filippo
    ANTICANCER RESEARCH, 2015, 35 (06) : 3625 - 3626
  • [22] Controversies in Radioiodine Treatment of Low- and Intermediate-risk Thyroid Cancer
    Eilsberger, F.
    Verburg, F. A.
    CLINICAL ONCOLOGY, 2021, 33 (02) : 68 - 74
  • [23] Focal low-dose-rate prostate brachytherapy for low- and intermediate-risk prostate cancer
    Kunogi, Hiroaki
    Wakumoto, Yoshiaki
    Kawamoto, Terufumi
    Oshima, Masaki
    Horie, Shigeo
    Sasai, Keisuke
    JOURNAL OF CONTEMPORARY BRACHYTHERAPY, 2020, 12 (06) : 554 - 561
  • [24] Biochemical Control and Toxicity Outcomes of Stereotactic Body Radiation Therapy Versus Low-Dose-Rate Brachytherapy in the Treatment of Low- and Intermediate-Risk Prostate Cancer
    Gogineni, Emile
    Rana, Zaker
    Soberman, Danielle
    Sidiqi, Baho
    D'Andrea, Vincent
    Lee, Lucille
    Potters, Louis
    Parashar, Bhupesh
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1232 - 1242
  • [25] VOLUMETRIC MODULATED ARC THERAPY(VMAT) FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER
    Shiraishi, Kenshiro
    Yamamoto, Kentaro
    Haga, Akihiro
    Sakumi, Akira
    Nomoto, Akihiro
    Nakagawa, Keiichi
    ANNALS OF ONCOLOGY, 2014, 25
  • [26] Risk-Adapted Treatment for Low- and Intermediate-Risk Acute Promyelocytic Leukemia
    Sanz, Miguel A.
    Montesinos, Pau
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 : S130 - S134
  • [27] Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
    Henk van der Poel
    Laurence Klotz
    Gerald Andriole
    Abdel-Rahmène Azzouzi
    Anders Bjartell
    Olivier Cussenot
    Freddy Hamdy
    Markus Graefen
    Paolo Palma
    Arturo Rodriguez Rivera
    Christian G. Stief
    World Journal of Urology, 2015, 33 : 907 - 916
  • [28] Hypofractionated Proton Radiation Therapy for Low- and, Intermediate-Risk Prostate Cancer Is Not Associated With Post-treatment Testosterone Suppression
    Kil, W.
    Nichols, R. C.
    Hoppe, B. S.
    Marcus, R. B.
    Mendenhall, W. M.
    Mendenhal, N. P.
    Li, Z.
    Costa, J. A.
    Williams, C. R.
    Henderson, R. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S375 - S375
  • [29] Role of active surveillance and focal therapy in low- and intermediate-risk prostate cancers
    van der Poel, Henk
    Klotz, Laurence
    Andriole, Gerald
    Azzouzi, Abdel-Rahmene
    Bjartell, Anders
    Cussenot, Olivier
    Hamdy, Freddy
    Graefen, Markus
    Palma, Paolo
    Rodriguez Rivera, Arturo
    Stief, Christian G.
    WORLD JOURNAL OF UROLOGY, 2015, 33 (07) : 907 - 916
  • [30] Toxicity and early treatment outcomes in low- and intermediate-risk prostate cancer managed by high-dose-rate brachytherapy as a monotherapy
    Ghadjar, Pirus
    Keller, Tamara
    Rentsch, Cyrill A.
    Isaak, Bernhard
    Behrensmeier, Frank
    Stroux, Andrea
    Thalmann, George N.
    Aebersold, Daniel M.
    BRACHYTHERAPY, 2009, 8 (01) : 45 - 51
12345